98
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Phenotype of hepatic xenobiotic metabolizing enzymes and CYP450 isoforms of sanguinarine treated rats: Effect of P450 inducers on its toxicity

&
Pages 510-517 | Received 25 Jul 2009, Accepted 07 Sep 2009, Published online: 30 Sep 2009

References

  • Babu CK, Khanna SK, Das M. 2006. Safety evaluation studies on argemone oil through dietary exposure for 90days in rats. Food Chem Toxicol 44:1151–1157.
  • Benson AM, Hunkeler MJ, Talalay P. 1980. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216–5220.
  • Bock KW, Lilienblum W, Fischer G, Schirmer G, Bock-Henning BS. 1987. The role of conjugation reactions in detoxication. Arch Toxicol 60:22–29.
  • Brandon EFA, Raap CD, Meijerman I, Beijnen JH, Schellens JHM. 2003. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233–246.
  • Das M, Ansari KM, Dhawan A, Shukla Y, Khanna SK. 2005b. Correlation of DNA damage in dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int J Cancer 117:709–717.
  • Das M, Babu K, Reddy NP, Srivastava LM. 2005a. Oxidative damage of plasma proteins and lipids in epidemic dropsy patients: alterations in antioxidant status. Biochim Biophys Acta 1722:209–217.
  • Das M, Khanna SK. 1997. Clinicoepidemiological, toxicological and safety evaluation studies on argemone oil. Crit Rev Toxicol 27:273–297.
  • Das M, Rastogi S, Khanna SK. 2004. Mechanism to study 1:1 stoichiometry of NADPH and alkoxyphenoxazones metabolism spectrophotometrically in subcellular biological preparations. Biochim Biophys Acta 1675:1–11.
  • Das M, Seth PK, Mukhtar H. 1981. Characterisation of microsomal aryl hydrocarbon hydroxylase in rat brain. J Pharmacol Exp Therap 216:156–161.
  • Dey A, Yadav S, Dhawan A, Seth PK, Parmar D. 2006. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes. Life Sci 79:1729–1735.
  • Dvorak Z, Sovadinova I, Blaha L, Giesy JP, Ulrichova J. 2006b. Quarternary bezo(c)phenanthridine alkaloids sanguinarine and chelerythrine do not transcriptional activity of aryl hydrocarbon receptor: analyses in rat hepatoma cell line H4IIE.luc. Food Chem Toxicol 44:1466–1473.
  • Dvorak Z, Zdarilova A, Sperlikova L, Anzenbacherova E, Simanek V, Ulrichova J. 2006a. Cytotoxicity of sanguinarine in primary rat hepatocytes is attenuated by dioxin and phenobarbital. Toxicol Lett 165:282–288.
  • Dwivedi PD, Das M, Khanna SK. 1998. Role of cytochrome P-450 in quinalphos toxicity: effect on hepatic and brain antioxidant enzymes in rats. Food Chem Toxicol 36:437–444.
  • Frei E, Gilberg F, Schroder M, Breuer A, Edler L, Wiessler M. 1999. Analysis of the inhibition of N-nitroso-dimethylamine activation in the liver by N-nitro-dimethylamine using a new non-linear statistical method. Carcinogenesis 20:459–464.
  • Guengerich FP. 1995. Human cytochrome P450 enzymes. In: Ortiz de Motellano PR (Ed.), Cytochrome P450: Structure, mechanism and biochemistry. New York: Plenum press. pp. 473–535.
  • Habig WH, Pabst MJ, Jacoby WB. 1974. Glutathione-S-transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139.
  • Laemmli UK. (1970). Cleavage and structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
  • Lin JH, Lu AY. 2001. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol 41:535–567.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with folin phenol reagent. J Biol Chem 193:265–275.
  • Nerurkar PV, Park SS, Thomas PE, Nims, RW, Lubet RA. 1993. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46:933–943.
  • Omura T, Sato R. 1964. Carbon monoxide binding pigment of rat liver microsomes. J Biol Chem 239:2370–2378.
  • Ortiz de Montellano PR, Corriea MA. 1983. Suicidal destruction of Cytochrome P450 during oxidative drug metabolism. Annu Rev Pharmacol Toxicol 23:481–503.
  • Parmar D, Yadav S, Dayal M, Johr A, Dhawan A, Seth PK. 2003. Effect of lindane on hepatic and brain cytochrome P450s and influence of P450 modulation in lindane induced neurotoxicity. Food Chem Toxicol 41:1077–1087.
  • Phillips AH, Langdon RG. 1962. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 237:2652–2660.
  • Pohl RJ, Fouts JR. 1980. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107:150–155.
  • Reddy NP, Khanna SK, Das M. 2003. Interaction of argemone alkaloid, sanguinarine with rat hepatic cytochrome P450. Poster presented at International Symposium on Molecular Toxicology Environmental Health, ITRC, 5–8 November.
  • Slawson MH, Franklin MR, Moody DE. 1996. Correlations of the induction of microsomal epoxide hydrolase activity with phase II drug conjugating enzyme activities in rat liver. Toxicol Lett 85:29–34.
  • Tandon S, Das M, Khanna SK. 1992. Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine in rats and guinea pigs, Drug Metab Disp 21:194–197.
  • Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to their nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354.
  • Upreti KK, Das M, Khanna SK. 1991a. Role of antioxidants and scavengers of argemone oil induced toxicity in rats. Arch Environ Contam Tox 20:531–537.
  • Upreti KK, Das M, Khanna SK. 1991b. Biochemical toxicology of argemone oil. I. Effect on hepatic cytochrome P-450 and xenobiotic metabolizing enzymes. J Appl Toxicol 11:203–209.
  • Upreti KK, Das M, Kumar A, Singh GB, Khanna SK. 1989. Biochemical toxicology of argemone oil IV: short-term oral feeding response in rats. Toxicology 58:285–298.
  • Vrba J, Kosina P, Ulrichova J, Modriansky M. 2004. Involvement of cytochrome P450 1A in sanguinarine detoxification. Toxicol Lett 151:375–387.
  • Wang RW, Newton DJ, Scheri TD, Lu AY. 1997. Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Drug Metab Dispos 25:502–507.
  • Waxman DJ, Azaroff L. 1992. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281:577–592.
  • Wilkinson JT, Clapper ML. 1997. Detoxification enzymes and chemoprevention. Proc Soc Exp Biol Med 216:192–200.
  • Williams MK, Dalvi S, Dalvi RR. 2000. Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice. Vet Hum Toxicol 42:196–198.
  • Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249–268.
  • Zdarilova A, Vrzal R, Rypka M, Ulrichova J, Dvorak Z. 2006. Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity in human hepatoma cells. Food Chem Toxicol 44:42–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.